This initiative aims to increase access to essential medicines for people in developing countries, by increasing transparency and accountability in medicines procurement and supply chains to tackle inefficiency, corruption and fraud.

The Medicines Transparency Alliance (MeTA) is a network of individuals and organizations in seven countries. The network includes health workers, administrators, civil servants, politicians, pharmaceutical company employees, civil society and international organizations and the media. The MeTA Management Board consists of the core group of the founding partners – the UK Department for International Development (DFID), the World Health Organisation (WHO) and the World Bank. The Board has provided overall guidance for the programme and has agreed the support provided to participating countries through the Secretariat.

The International Advisory Group has supported the overall work of MeTA with a particular commitment to its transparency and accountability goals. It consisted of elected representatives from each pilot country and a number of experts drawn from international organisations, academia and the private sector.

The goal of the initiative is to improve the lives of millions by helping them get access to the medicines they need, through the use of the tools of transparency and accountability.